Trial Profile
A proof of concept study of HLD-400 as potential therapy for inflammatory bowel disease using scintigraphy imaging
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 30 May 2016
Price :
$35
*
At a glance
- Drugs HLD 400 (Primary)
- Indications Inflammatory bowel diseases
- Focus Pharmacodynamics; Pharmacokinetics; Proof of concept
- 30 May 2016 New trial record